|
|
News for Healthier Living
Reversing T Cell Exhaustion Improves Effectiveness of Myeloma Immunotherapies
Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb, and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma. In two studies published this month in Blood, the Journal of the American Society of Hematology, (doi.org/10.1182/blood.2025030891 and 10.1182/blood.2025030873) they found that using the drug mezigdomide (a cereblon E3 ligase modulator developed by Bristol Myers Squibb) can help these cells regain their strength and better destroy cancer by restoring the immune system's ability to attack cancer and significantly improving the effectiveness of next-generation immunotherapies.
May 18, 2026
May 19 2026May 18 2026May 17 2026May 16 2026May 15 2026May 14 2026May 13 2026May 12 2026May 11 2026 - Diabetes, Weight-Loss Drugs Not a Perfect Fit?
- Hidden Cell "Message Route" Could Shift Cancer Research
- Urine Test Better Than Mri for Monitoring Low-Risk Prostate Cancer in New Study
- Researchers Track the Mutations That Allow HIV-1 to Escape Broadly Neutralizing Antibodies
- Low-Dose Radiation Therapy for Osteoarthritis Now Offered at UC San Diego Health
- Moffitt Study Suggests Immunotherapy May Strengthen Treatment for Aggressive Prostate Cancer
- Stroke's Alarming Rise in Younger Americans Underscores Urgent Need for New Rehab Approach
- Understanding Clinical Trials: What Patients Need to Know
- Persistent Hunger May Be Behind Weight Regain After Loss
- Single Screening Sigmoidoscopy Linked to Lower Colorectal Cancer Risk Two Decades Later
- Heat-Related Hospitalizations Rose Nationwide Over Two Decades, with Black Adults and Low-Income Communities Disproportionately Affected
- ACP Says Telemedicine Can Offer Safe, Equitable, and Effective Access to Clinical Care, but Improvements to the Regulatory Landscape Are Needed
- New Commentary Shares Strategies to Address the Primary Care Physician Shortage
- FDA Green Lights Bizengri Drug To Treat Rare, Aggressive Bile Duct Cancer
- 8,500 Steps A Day Could Be Sweet Spot For Preventing Weight Regain
- Telemedicine Has Not Led to Increased Use of Medical Care or Higher Health Care Costs, New UCLA-Led Research Finds
- After Decades of Mystery Pain, UTHealth Houston Physician Delivers a Diagnosis
- Older Adults Have Fewer Regrets, Study Says
- Why Doctors Are Quitting At An Earlier Age
- Sharper Brains May Face Higher Depression Relapse Risk, Study Finds
- Vertigo Can Carry Lasting Burden Even After Successful Treatment, Seven-Year Study Finds
- New Research Identifies How Obesity Alters Brain Lipids to Accelerate Alzheimer's Progression
- Nighttime Heat Waves Increase Asthma Risk
- Safer Surgeries Through Laser-Induced Acoustic Imaging #ASA190
- That Discount At The Pharmacy Counter May Pack Hidden Costs
- New Clues to Disease Severity Identified in alpha1-Antitrypsin Deficiency
- Love Multiplied by Four
- From the Fairway to the Hallways of Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center
May 10 2026May 8 2026May 7 2026May 6 2026May 5 2026
|
|
|
|
|